Early detection of poor glycemic control in patients with diabetes mellitus in sub-Saharan Africa: a cohort study in Mozambique.
Diabetes Mellitus
Health Care
Non-Communicable Diseases
Journal
African health sciences
ISSN: 1729-0503
Titre abrégé: Afr Health Sci
Pays: Uganda
ID NLM: 101149451
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
medline:
25
4
2023
pubmed:
24
4
2023
entrez:
24
04
2023
Statut:
ppublish
Résumé
WHO estimates 422 million cases of diabetes mellitus worldwide. Mozambique has the second-highest mortality related to DM in the African region.Objectives of the present study are to provide data about a DM care service in Mozambique and to evaluate early outcomes of treatment. The new patients diagnosed with DM in a two-years period in a health centre in Maputo (Mozambique) were included in a retrospective cohort study. Fasting blood glucose (FBG), waist circumference (WC) and BMI were collected at baseline and after three months. 188 patients were enrolled. Median BMI, WC and FBG at baseline were respectively 28 kg/m2(Inter Quartile Range [IQR]23.4-31.8), 98cm (IQR 87-105) and 209mg/dL (IQR 143-295). A non-pharmacological intervention was prescribed for six patients, while 182 patients received metformin 500 mg b.i.d. FBG was significantly reduced at control (226[±103.7]mg/dL vs 186[±93.2]mg/dL, p<0.000); however, glycemic control was reached in 74 patients (39.4%); not controlled patients changed regimen. Elderly patients had a higher glycemic control (adjusted Odds Ratio 2.50, 95% CI 1.11-5.06, p=0.002). Strategies for early detection of scarce glycemic control are feasible in Mozambique and could lead to prompt regimen switch; an invasive therapeutic approach could be preferable in selected cases to achieve control.
Identifiants
pubmed: 37092081
doi: 10.4314/ahs.v22i4.16
pii: jAFHS.v22.i4.pg127
pmc: PMC10117463
doi:
Substances chimiques
Blood Glucose
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
127-132Informations de copyright
© 2022 Ciccacci F et al.
Déclaration de conflit d'intérêts
The authors declare no competing interest.
Références
Diabetes Res Clin Pract. 2015 Apr;108(1):187-92
pubmed: 25697633
Pan Afr Med J. 2021 Jan 29;38:102
pubmed: 33889268
Pediatr Infect Dis J. 2014 Mar;33(3):295-300
pubmed: 23799517
Int J Gen Med. 2017 Feb 20;10:33-38
pubmed: 28260942
J Clin Endocrinol Metab. 2019 May 1;104(5):1520-1574
pubmed: 30903688
Diabetologia. 2017 Sep;60(9):1586-1593
pubmed: 28770321
Pan Afr Med J. 2020 Sep 14;37:49
pubmed: 33209176
Lancet. 2006 Nov 11;368(9548):1689-95
pubmed: 17098088
Heart. 2008 Nov;94(11):1376-82
pubmed: 18519551
Global Health. 2009 Sep 14;5:9
pubmed: 19751503
Diabet Med. 2006 May;23(5):469-80
pubmed: 16681555
Curr HIV/AIDS Rep. 2018 Jun;15(3):223-232
pubmed: 29700760
Lancet. 2010 Jun 26;375(9733):2254-66
pubmed: 20609971
Ann Intern Med. 2017 Feb 21;166(4):279-290
pubmed: 28055075
BMC Res Notes. 2018 May 18;11(1):316
pubmed: 29776447
AIDS Res Hum Retroviruses. 2019 Nov/Dec;35(11-12):1106-1111
pubmed: 31468993
Clin Infect Dis. 2017 Nov 13;65(11):1878-1883
pubmed: 29020319
HIV AIDS (Auckl). 2017 Nov 08;9:193-202
pubmed: 29184449
Arch Intern Med. 2005 May 23;165(10):1179-84
pubmed: 15911733
Diabetes Res Clin Pract. 2014 Feb;103(2):197-205
pubmed: 24315460
Diabetes Metab. 2011 Jun;37(3):237-44
pubmed: 21236716